GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhoenixBio Co Ltd (TSE:6190) » Definitions » ROE % Adjusted to Book Value

PhoenixBio Co (TSE:6190) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is PhoenixBio Co ROE % Adjusted to Book Value?

PhoenixBio Co's ROE % for the quarter that ended in Sep. 2024 was 0.00%. PhoenixBio Co's PB Ratio for the quarter that ended in Sep. 2024 was 1.08. PhoenixBio Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 0.00%.


PhoenixBio Co ROE % Adjusted to Book Value Historical Data

The historical data trend for PhoenixBio Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhoenixBio Co ROE % Adjusted to Book Value Chart

PhoenixBio Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.65 -11.41 -19.32 28.46 1.47

PhoenixBio Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.01 -2.81 -2.92 2.49 -

Competitive Comparison of PhoenixBio Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, PhoenixBio Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's ROE % Adjusted to Book Value falls into.



PhoenixBio Co ROE % Adjusted to Book Value Calculation

PhoenixBio Co's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=1.59% / 1.08
=1.47%

PhoenixBio Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 1.08
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhoenixBio Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PhoenixBio Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PhoenixBio Co Business Description

Traded in Other Exchanges
N/A
Address
3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics related test, safety test, hepatitis virus (HBV / HCV) related drug efficacy test.

PhoenixBio Co Headlines

No Headlines